Sullivan Timothy Eugene

Sullivan Timothy Eugene is listed in filings as Chief Financial Officer at Apellis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including sale activity. Recent filings connect the profile to Apellis Pharmaceuticals, Inc. (APLS). The current snapshot covers public activity from Jun 11, 2025 to May 14, 2026. Reported amounts are shown as $3.1M to $2.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.